Follow-The-Filings

Security

Akebia Therapeutics Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

8 owners max 0.0% (Vanguard Group Inc.)

owners 8
max % 0.0%
tracked value $36M
qoq A 5 R 2

holders

sorted by % of portfolio · long equity only

manager % port activity shares value history
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 16,016,448 $26M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Add 0.00 pp 2,384,713 $3M hist
Renaissance Technologies LLC 2026 Q1 0.0% Reduce 0.00 pp 1,833,128 $3M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Add 0.00 pp 1,792,620 $2M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Reduce 0.00 pp 1,390,067 $2M hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit 0.00 pp 90,619 $146 hist
Joel Greenblatt - Gotham Asset Management, LLC 2026 Q1 0.0% Add 0.00 pp 27,172 $38 hist
D. E. Shaw & Co., Inc. 2026 Q1 0.0% Add 0.00 pp 16,106 $22 hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $194.62M $160.18M $236.2M
Gross profit * $120.47M $97M $196.73M
Gross margin * 61.9% 60.6% 83.3%
Net income -$51.92M -$69.41M -$5.34M
Net margin * -26.7% -43.3% -2.3%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $118.15M $113.83M $252.96M
Total non-current assets * $123.55M $106.84M $123.61M
Total assets $241.7M $220.67M $376.56M
Total current liabilities $99.87M $80.91M $162.94M
Total non-current liabilities * $172.42M $188.94M $181.02M
Total equity -$30.58M -$49.18M $32.61M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$23.38M -$40.66M $67.99M
Cash from investing $0.00 -$33,000 -$7.93M
Cash from financing -$25.21M $49.66M $72.93M
Net change in cash -$48.59M $8.97M $132.99M

ownership over time

filing count by report period · click a bar for that quarter’s holders